Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
movement disorder |
| gptkbp:alsoKnownAs |
gptkb:DIP
|
| gptkbp:causedBy |
calcium channel blockers
medications antipsychotics antiemetics dopamine antagonists |
| gptkbp:designer |
usually
|
| gptkbp:differentialDiagnosis |
gptkb:Parkinson's_disease
gptkb:essential_tremor |
| gptkbp:firstDescribed |
1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Drug-Induced Parkinsonism
|
| gptkbp:ICD-10_code |
G21.1
|
| gptkbp:MeSH_ID |
D010300
|
| gptkbp:prevalence |
second most common cause of parkinsonism
|
| gptkbp:riskFactor |
elderly
female gender |
| gptkbp:symptom |
bradykinesia
postural instability rigidity tremor |
| gptkbp:treatment |
gptkb:amantadine
discontinuation of causative drug anticholinergic medications |
| gptkbp:bfsParent |
gptkb:D010141
|
| gptkbp:bfsLayer |
7
|